ASX:AFICapital Markets
Is AFIC’s Move Into Biotechnology a Meaningful Shift in Its Capital Allocation Strategy (ASX:AFI)?
Australian Foundation Investment Company recently reported a decline in full-year profit, driven by lower dividends following a reduction in bank holdings, but maintained its final dividend and declared a special fully franked dividend, which lifted total dividend payments by 21%.
This period also saw the company reshape its portfolio by reducing certain exposures and adding new investments like Telix Pharmaceuticals, reflecting a shift towards growth opportunities in targeted cancer...